MAALOX / MYLANTA
What it isA combination antacid pairing aluminum hydroxide with magnesium hydroxide to neutralize gastric acid.
Why this oneCombining the two balances aluminum's constipating effect against magnesium's laxative effect for better GI tolerability than either alone.
What limits itLike other polyvalent-cation antacids it binds fluoroquinolones, tetracyclines, and other drugs, and both cations can accumulate dangerously in renal impairment.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Antacid / antigas (per Drug Facts Purpose) | Adults and children >=12 y | 2-4 tsp (10-20 mL) QID, or as directed by a physician | 2-4 tsp (10-20 mL) QID | 16 tsp (80 mL)/24 h; do not use maximum dosage >2 weeks |
| Antacid / antigas (per Drug Facts Purpose) | Children <12 y | Consult a physician | Consult a physician | Not stated |
Renal Ask a doctor before use if you have kidney disease (OTC label; no dose adjustment given)
Hepatic Undefined
Do not exceed 16 teaspoonfuls in 24 h, or use the maximum dosage for more than 2 weeks, except under physician supervision
Pregnancy Undefined
Lactation Undefined
NO BOXED WARNINGS
Principal riskNo FDA boxed warning.
